July 10, 2024 01:15 PM EDT

House committee raises concerns on CDER-CBER misalignment amid 2025 funding markup

Zachary Brennan

Senior Editor

The House Appropriations Committee on Wednesday began marking up the FDA’s 2025 funding bill, offering the agency about 1% less than 2024 and almost 10 …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

House committee raises concerns on CDER-CBER misalignment amid 2025 funding markup

Zachary Brennan

Senior Editor

Sign up to read this article for free.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

Exclusive: Influential Democrat will oppose Biosecure Act ahead of House vote

Astellas CEO talks future beyond Xtandi as Japanese drugmaker puts roots in Boston

BridgeBio sticks to script for ATTR-CM as Alnylam cleans up ‘typo’ snafu

Roche's Spark loses CEO to RNA upstart; Ex-Elevation Oncology chief takes over at Affimed

Lilly inks obesity deal with seed-stage RNA startup as its genetic medicines effort enters the spotlight

How to secure full enrollment and a 30x ROI: A conversation with the CEO of the boutique enrollment agency doing just ...

House com­mit­tee rais­es con­cerns on CDER-CBER mis­align­ment amid 2025 fund­ing markup

Senior Editor

Sign up to read this article for free.

Viridian Therapeutics

Waltham, MA, USA

House committee raises concerns on CDER-CBER misalignment amid 2025 funding markup